Intarcia Therapeutics' Series E - III Round

Intarcia Therapeutics raised a round of funding on April 03, 2017.

Intarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging disea…

Articles about Intarcia Therapeutics' Series E - III Round: